DiaSorin (OTCMKTS:DSRLF) Downgraded to Hold Rating by UBS Group

DiaSorin (OTCMKTS:DSRLF) was downgraded by stock analysts at UBS Group from a “strong-buy” rating to a “hold” rating in a report released on Tuesday,Zacks.com reports.

DiaSorin Stock Performance

DiaSorin stock opened at $107.88 on Tuesday. The firm’s 50-day moving average is $103.07 and its 200-day moving average is $103.07. DiaSorin has a 1 year low of $107.88 and a 1 year high of $107.88.

DiaSorin Company Profile

DiaSorin S.p.A. engages in development, manufacture, and distribution of immunodiagnostics and molecular diagnostics testing kits in Europe, Africa, North America, Central and South America, the Asia Pacific, and China. The company provides various immunodiagnostic LIAISON platforms, including LIAISON XS, LIASON IQ, LIAISON XL, LIAISON XXL, and LIAISON XL LAS.